A2AR mediates collagen type 1 expression through different pathways, such as cAMP and AKT [35]; in fact, its pharmacological inhibition abrogates fibrosis in murine models of scleroderma and fibrosis by modulating these pathways [47]. The gene discussed is ADORA2A; the disease is scleroderma.